Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Founded by Harris Fienberg and Mike Angelo in 2014, Ionpath is backed by investors that include Paladin Partners Investments, Samsara BioCapital, Bruker, Genoa Ventures, and Vertical Venture Partners and is headquartered in Menlo Park.